z-logo
open-access-imgOpen Access
Successful treatment of herpes simplex virus associated hemophagocytic syndrome coexisting with ARDS with intravenous immunoglobulin in acute myeloid leukemia patient
Author(s) -
IHsuan Huang,
Wei-Chun Lin,
PingYing Chang
Publication year - 2017
Publication title -
journal of cancer research and practice
Language(s) - English
Resource type - Journals
eISSN - 2589-0425
pISSN - 2311-3006
DOI - 10.1016/j.jcrpr.2017.02.003
Subject(s) - medicine , ards , hemophagocytic lymphohistiocytosis , herpes simplex virus , immunology , antibody , myeloid leukemia , virus , lung , disease
Hemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome characterized by excessive macrophage function. The diagnosis of HLH in adults is challenging because initial signs and symptoms of HLH mimic common infections. Herein is described a case of HSV infection causing virus-associated hemophagocytic syndrome (VAHS) with severe hemodynamic distress. This patient manifested acute respiratory distress syndrome (ARDS), which responded well to intravenous immunoglobulin. Patients with herpes simplex virus-associated hemophagocytic syndrome coexisting with ARDS may be given a trial of immune globulin. However, there are few reported cases of AML occurring with VAHS in the literature, which were successfully treated with IVIG; therefore, this finding requires further investigation in a similar setting

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom